Mycotic aortic aneurysm due to intravesical BCG immunotherapy: Clinical manifestations and diagnostic challenges
- Holmes, Brittany J.
- LaRue, Richard W.
- Black, James H.
- Dionne, Kim
- Parrish, Nicole M.
- Melia, Michael T.
Publication date
March 2014
DOI Publisher
Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. ISSN
2212-5531 Citation count (estimate)
3Abstract
AbstractA live, attenuated form of Mycobacterium bovis, bacillus Calmette–Guérin (BCG), is commonly used as intravesical immunotherapy for non-invasive urothelial bladder carcinoma. While complications are rare, dissemination can occur. A case of mycotic aortic aneurysm following BCG administration with recovery of Mycobacterium bovis in culture is reported. A review of the published experience with this problem is also presented
Add to ORKG